These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29310082)

  • 21. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability.
    Pecic S; Zeki AA; Xu X; Jin GY; Zhang S; Kodani S; Halim M; Morisseau C; Hammock BD; Deng SX
    Prostaglandins Other Lipid Mediat; 2018 May; 136():90-95. PubMed ID: 29567338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
    Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
    Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.
    Kim IH; Morisseau C; Watanabe T; Hammock BD
    J Med Chem; 2004 Apr; 47(8):2110-22. PubMed ID: 15056008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea.
    Watanabe T; Morisseau C; Newman JW; Hammock BD
    Drug Metab Dispos; 2003 Jul; 31(7):846-53. PubMed ID: 12814960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
    Hwang SH; Morisseau C; Do Z; Hammock BD
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of potent inhibitors of the chicken soluble epoxide hydrolase.
    Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C
    Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Wang S; Xu S; Chen HS; Tong X; Tong V; Mitra K; Kumar S; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Chen X; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3398-404. PubMed ID: 19481932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
    Morisseau C; Goodrow MH; Newman JW; Wheelock CE; Dowdy DL; Hammock BD
    Biochem Pharmacol; 2002 May; 63(9):1599-608. PubMed ID: 12007563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of soluble epoxide hydrolase by natural isothiocyanates.
    Elbarbry F; Espiritu MJ; Soo K; Yee B; Taylor J
    Biochem Biophys Res Commun; 2024 Sep; 725():150261. PubMed ID: 38897040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
    Anandan SK; Webb HK; Do ZN; Gless RD
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
    Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
    Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.